The fully operational site is the world's largest plasma fractionation facility of its kind. It has boosted CSL Behring’s capacity in Australia by nine times, now processing over 10 million litres of plasma each year.
CSL Behring wins major international pharmaceutical engineering award
May 14, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
Mark Butler restates support for health technology assessment reform
July 16, 2025 - - Latest News -
Brandon BioCatalyst welcomes the inclusion of its CUREator in new program
July 16, 2025 - - Australian Biotech -
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech -
Lumos Diagnostics signs FebriDx US Distribution Agreement with PHASE Scientific
July 16, 2025 - - Australian Biotech -
Noxopharm confirms first patient dosed in SOF-SKN HERACLES trial
July 16, 2025 - - Australian Biotech